Incidence and Prevalence of Patients with Myelodysplastic Syndromes (MDS) in Dusseldorf 1996-2005

被引：0
|
作者：
Neukirchen, J. [1 ]
Germing, U. [1 ]
Aul, C. [2 ]
Gattermann, N. [1 ]
Schoonen, M. [3 ]
Haas, R. [1 ]
机构：
[1] Univ Dusseldorf, Klin Hamatol Onkol & Klin Immunol, D-4000 Dusseldorf, Germany
[2] St Johannes Hosp Duisburg, Med Klin 2, Duisburg, Germany
[3] Amgen Ltd, Cambridge, England
来源：
MEDIZINISCHE KLINIK | 2010年 / 105卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：212 / 213
页数：2
相关论文
共 50 条
  • [21] Serum cytokine levels in patients with myelodysplastic syndromes (MDS).
    Allampallam, K
    Shetty, V
    Mundle, S
    Dutt, D
    Reddy, PL
    Alvi, S
    Galili, N
    Saberwal, GS
    Anthwal, S
    Shaikh, MW
    York, A
    Gezer, S
    Venugopal, P
    Raza, A
    BLOOD, 2001, 98 (11) : 269B - 270B
  • [22] CHROMOSOMAL RESULTS IN 50 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    LESSARD, M
    BRIZARD, A
    GUILHOT, F
    TANZER, J
    BLUT, 1988, 56 (06): : C9 - C9
  • [23] Childhood cancer: incidence and spatial patterns in the city of Campinas, Brazil, 1996-2005
    Oliveira Friestino, Jane Kelly
    Mendonca, Denisa
    Oliveira, Pedro
    Oliveira, Carla M.
    Moreira Filho, Djalma de Carvalho
    SALUD COLECTIVA, 2018, 14 (01): : 51 - 63
  • [24] Prevalence of cryptococcal meningitis at a tertiary care centre in Western India (1996-2005)
    Satpute, Meena G.
    Telang, Nilima V.
    Litake, Geetanjali M.
    Niphadkar, Krishna B.
    Joshi, Suresh G.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 55 (09) : 1301 - 1302
  • [25] Treatment and outcome of 23 paediatric patients with myelodysplastic syndromes (MDS)
    Polychronopoulou, S
    Panagiotou, JP
    Papadakis, V
    Parcharidou, A
    Psiachou, H
    Mavrou, A
    Haidas, S
    LEUKEMIA, 2000, 14 (05) : 969 - 969
  • [26] Clonal Heterogeneity in Patients with Myelodysplastic Syndromes (MDS) and Complex Karyotypes
    Zemanova, Zuzana
    Michalova, Kyra
    Brezinova, Jana
    Lhotska, Halka
    Svobodova, Karla
    Sarova, Iveta
    Lizcova, Libuse
    Izakova, Silvia
    Ransdorfova, Sarka
    Krejcik, Zdenek
    Belickova, Monika
    Siskova, Magda
    Jonasova, Anna
    Neuwirtova, Radana
    Zmolikova, Jana
    Cermak, Jaroslav
    BLOOD, 2014, 124 (21)
  • [27] Phase II study of amifostine in patients with myelodysplastic syndromes (MDS).
    List, AF
    Holmes, H
    Greenberg, PL
    Bennett, JM
    Oster, W
    BLOOD, 1999, 94 (10) : 305A - 305A
  • [28] Clinical Experience of Decitabine in Elderly Patients with Myelodysplastic Syndromes (MDS)
    Geils, George F., Jr.
    BLOOD, 2009, 114 (22) : 1092 - 1092
  • [29] Characteristics and Outcome Of Myelodysplastic Syndromes (MDS) Patients With Autoimmune Diseases
    Komrokji, Rami S.
    Kulasekararaj, Austin G.
    Al Ali, Najla H.
    Kordasti, Shahram Y.
    Bart-smith, Emily
    Benjamin, Craig
    Padron, Eric
    Zhang, Ling
    Lancet, Jeffrey E.
    List, Alan
    Mufti, Ghulam J.
    Epling-Burnette, Pearlie K.
    BLOOD, 2013, 122 (21)
  • [30] Model Heterogeneity in Predicting Outcomes of Patients with Myelodysplastic Syndromes (MDS)
    Al-Issa, Karam
    Madanat, Yazan F.
    Mukherjee, Sudipto
    Hirsch, Cassandra M.
    Gerds, Aaron T.
    Abuhadra, Nour
    Makhoul, Ahed
    Awada, Hassan
    Asad, Mohammad Fahad B.
    Goyal, Abhinav
    Advani, Anjali S.
    Kuzmanovic, Teodora
    Przychodzen, Bartlomiej P.
    Carraway, Hetty E.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    Nazha, Aziz
    BLOOD, 2017, 130
12345